Literature DB >> 4327086

L-asparaginase in the treatment of neoplastic diseases in children.

N Jaffe, D Traggis, L Das, W C Moloney, H W Hann, B S Kim, R Nair.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4327086

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  18 in total

Review 1.  Chemotherapy of childhood lymphoblastic leukaemia: the first 50 years.

Authors:  J Lilleyman
Journal:  Paediatr Drugs       Date:  1999 Jul-Sep       Impact factor: 3.022

Review 2.  Cancer cell metabolism: the essential role of the nonessential amino acid, glutamine.

Authors:  Ji Zhang; Natalya N Pavlova; Craig B Thompson
Journal:  EMBO J       Date:  2017-04-18       Impact factor: 11.598

3.  Genetic variations in GRIA1 on chromosome 5q33 related to asparaginase hypersensitivity.

Authors:  S-H Chen; D Pei; W Yang; C Cheng; S Jeha; N J Cox; W E Evans; C-H Pui; M V Relling
Journal:  Clin Pharmacol Ther       Date:  2010-06-30       Impact factor: 6.875

4.  Asparagine synthetase expression alone is sufficient to induce l-asparaginase resistance in MOLT-4 human leukaemia cells.

Authors:  A M Aslanian; B S Fletcher; M S Kilberg
Journal:  Biochem J       Date:  2001-07-01       Impact factor: 3.857

5.  Erwinia asparaginase achieves therapeutic activity after pegaspargase allergy: a report from the Children's Oncology Group.

Authors:  Wanda L Salzer; Barbara Asselin; Jeffrey G Supko; Meenakshi Devidas; Nicole A Kaiser; Paul Plourde; Naomi J Winick; Gregory H Reaman; Elizabeth Raetz; William L Carroll; Stephen P Hunger
Journal:  Blood       Date:  2013-06-05       Impact factor: 22.113

6.  Multiple adaptive mechanisms affect asparagine synthetase substrate availability in asparaginase-resistant MOLT-4 human leukaemia cells.

Authors:  A M Aslanian; M S Kilberg
Journal:  Biochem J       Date:  2001-08-15       Impact factor: 3.857

7.  Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase.

Authors:  Shotaro Iwamoto; Keichiro Mihara; James R Downing; Ching-Hon Pui; Dario Campana
Journal:  J Clin Invest       Date:  2007-03-22       Impact factor: 14.808

8.  Clinical course and outcome in children with acute lymphoblastic leukemia and asparaginase-associated pancreatitis.

Authors:  Susan L Kearney; Suzanne E Dahlberg; Donna E Levy; Stephan D Voss; Stephen E Sallan; Lewis B Silverman
Journal:  Pediatr Blood Cancer       Date:  2009-08       Impact factor: 3.167

Review 9.  Asparaginase-Associated Pancreatitis in Pediatric Patients with Acute Lymphoblastic Leukemia: Current Perspectives.

Authors:  Amber Gibson; Carlos Hernandez; Fiorela N Hernandez Tejada; Jitesh Kawedia; Michael Rytting; Branko Cuglievan
Journal:  Paediatr Drugs       Date:  2021-08-05       Impact factor: 3.022

10.  Deficiency in asparagine synthetase expression in rectal cancers receiving concurrent chemoradiotherapy: negative prognostic impact and therapeutic relevance.

Authors:  Ching-Yih Lin; Ming-Jen Sheu; Chien-Feng Li; Sung-Wei Lee; Li-Ching Lin; Yi-Fong Wang; Shang-Hung Chen
Journal:  Tumour Biol       Date:  2014-04-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.